Cochlear (ASX:COH) will continue to operate under a duty-free arrangement with the US as it awaits clarity on recent trade developments, the maker of hearing implants said in a Tuesday filing with the Australian bourse.
Cochlear is currently under the Harmonized Tariff Schedule of the US that provides duty-free importation on a range of products into the US, including hearing implants, per the filing.
The company said it will "continue to actively monitor and engage in the evolving global landscape" in line with the imposition of a 10% tariff on exports to the US from Australia.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.